Phase II randomised, double-blind study of mFOLFIRINOX plus ramucirumab versus mFOLFIRINOX plus placebo in advanced pancreatic cancer patients (HCRN GI14-198).
Metadata only so far. Questions are answered only with quotes from this document. Source: OpenAlex, Europe PMC, retrieved 2026-11-05.
Record metadata
- Journal
- Eur J Cancer
- Date
- 2023-03-11
- Citations
- 11
- Type
- article
Not in the data yet: a study card. A one-glance card (population, design, endpoints, result, each tied to a quote) is not built yet. The fields above are registry or bibliographic metadata, not quotes.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you get that instead of a guess.
Source text
No passages are loaded for this document yet.